Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy
/in International Publications, Malignant Melanoma /von 2008-05-01 / J. Immunother. 2008 May;31(4):345-58Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma
/in International Publications, Malignant Melanoma /von 2008-05-01 / J. Immunother. 2008 May;31(4):402-12Immunotherapy of pancreatic carcinoma
/in International Publications, Pancreatic Cancer /von 2008-05-01 / Rev Recent Clin Trials 2008 May;3(2):121-5Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-9Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
/in Chronic Leukemia, International Publications /von 2008-04-21 / J. Leukoc. Biol. 2008 Jul;84(1):319-25Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model
/in Glioblastoma, International Publications /von 2008-04-15 / Int. J. Cancer 2008 Apr;122(8):1794-802Cell- and peptide-based immunotherapeutic approaches for glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2008-04-09 / Trends Mol Med 2008 May;14(5):228-35Strategies and challenges in eliciting immunity to melanoma
/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:28-42An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):777-89
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de